Regenxbio Q3 EPS $(0.94) Misses $(0.72) Estimate, Sales $14.7 Miss $9.74M Estimate

Regenxbio (NASDAQ:RGNX) reported quarterly losses of $(0.94) per share which missed the analyst consensus estimate of $(0.72) by 30.56 percent. This is a 67.86 percent decrease over losses of $(0.56) per share from the

Benzinga · 11/05/2019 21:18

Regenxbio (NASDAQ:RGNX) reported quarterly losses of $(0.94) per share which missed the analyst consensus estimate of $(0.72) by 30.56 percent. This is a 67.86 percent decrease over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $14.7 which missed the analyst consensus estimate of $9.74 million by 100.00 percent. This is a 100.00 percent decrease over sales of $5.306 million the same period last year.